
Long-Term Administration of Second-Line Chemotherapy with S-1 and Gemcitabine for Platinum-Resistant Non-small Cell Lung Cancer: A Phase II Study
Keywords: Gemcitabine; Maintenance; Non-small cell lung cancer; S-1; Second-line therapy